1. 374 Real world prognostic relevance of residual disease and other clinical factors on the progression of disease and death in patients with advanced ovarian cancer in the US. (4th December 2020) Authors: Chase, Dana; Perhanidis, Jessica; Gupta, Divya; Kalilani, Linda; Sansbury, Leah; Woodward, Tatia; González-Martín, Antonio Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-708-ESGO Real-world assessment of patients with ovarian cancer who received niraparib as second-line maintenance therapy in the United States: did first-line maintenance approval change the patient profile for second-line maintenance therapy?. (20th October 2022) Authors: Backes, Floor; Calderón Boyle, Tirza Areli; Perhanidis, Jessica; Lim, Jonathan; Kalilani, Linda; Hurteau, Jean A; Golembesky, Amanda; Salani, Ritu Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗